Can a common antifungal drug help fight brain cancer? new study investigates
NCT ID NCT07585851
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase trial is testing whether ketoconazole, a drug normally used for fungal infections, can get into brain tumors (gliomas) in enough amounts to possibly slow their growth. About 80 adults with different grades of glioma will take low doses of the drug before their scheduled surgery. Researchers will measure drug levels in the tumor tissue and blood to see if it crosses the blood-brain barrier, which could lead to future studies using similar drugs for glioma treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIFFUSE GLIOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Brain Center Hospital Prof. Dr. dr. Mahar Mardjono
Jakarta, Jakarta Special Capital Region, 13630, Indonesia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a targeted pill slow brain tumor growth after surgery?
- Could a nurse-led online therapy beat severe fatigue in advanced cancer?
- Brain tumor drug trial fizzles: only 3 patients enrolled
- New scan may reveal brain tumor drug effects in weeks, not years
- New imaging test may help doctors spot real tumor growth in kids with brain cancer
- New trial tests if proton beam therapy spares brain function better than standard X-Rays